The transaction, approved by both companies' boards of directors, is expected to close by the end of the first quarter of 2026
The program will offer a structured and immersive learning experience for over 20,000 healthcare professionals across more than 10 cities
The agreement includes plans for distribution, technology transfer, local manufacturing, new pharmaceutical product development
LEQSELVI now available for prescription in U.S. nationwide, offering a new option for eligible patients
The UK authorization is based on positive results from the Phase III OASIS-1, -2, and -3 trials
Insights are drawn from over 30K+ people across 300+ cities including all metro and tier-1 cities
India’s fertility rate has dropped to 1.9, below the replacement level of 2.1
The Stryker Mako Robotic System uses artificial intelligence to improve surgical accuracy with real-time guidance, personalized planning, and precise execution
Subscribe To Our Newsletter & Stay Updated